New weight loss drug WVE-007 enters early human testing
NCT ID NCT06842186
First seen Nov 18, 2025 · Last updated May 03, 2026 · Updated 22 times
Summary
This early-stage study is testing a new drug called WVE-007 in 136 adults with overweight or obesity (BMI 28-35). The main goal is to check if the drug is safe and how the body handles it. Participants will receive either the drug or a placebo as a single injection, and researchers will monitor side effects and drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY AND OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ARENSIA Research Clinic
RECRUITINGChisinau, MD-2025, Moldova
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Arensia Clinics S.R.L.
RECRUITINGBucharest, 011658, Romania
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Parexel International Early Phase Clinical Unit
RECRUITINGHarrow, HA1 3UJ, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Parexel International-EPCU Baltimore
RECRUITINGBaltimore, Maryland, 21225, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Simbec-Orion Clinical Pharmacology
RECRUITINGMerthyr Tydfil, CF48 4DR, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Spitalul Clinic Judetean De Urgenta Cluj
RECRUITINGCluj-Napoca, 400006, Romania
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.